Understanding Why Smokers Don't Fully Switch to E-cigarettes
Misperceptions that prevent complete switching to e-cigarettes among adult smokers: A more nuanced communication strategy
This project aims to understand why adult smokers might not fully switch to e-cigarettes and to create better messages to help them make informed choices.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11129883 on NIH RePORTER |
What this research studies
Many adult smokers find it hard to quit, and while stopping all nicotine is best, switching completely to e-cigarettes can reduce exposure to harmful chemicals. However, some people mistakenly believe e-cigarettes are as dangerous as regular cigarettes, which stops them from switching. This project will explore the reasons behind these beliefs and develop clear, effective messages to explain the differences in harm. We will also use advanced brain imaging techniques to see how people respond to these messages, aiming to improve how we communicate health information.
Who could benefit from this research
Good fit: This research is for adult smokers who are at least 21 years old and may be considering switching to e-cigarettes or are interested in understanding health communication.
Not a fit: Patients who have already successfully quit all tobacco and nicotine products may not directly benefit from this specific communication research.
Why it matters
Potential benefit: If successful, this work could lead to clearer public health messages that help adult smokers understand the relative risks of e-cigarettes and potentially switch to less harmful options.
How similar studies have performed: While some research exists on tobacco messaging, this project explores underlying beliefs and uses neurocognitive measures, offering a novel approach to communication strategy development.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Weiger, Caitlin Victoria — Rutgers Biomedical and Health Sciences
- Study coordinator: Weiger, Caitlin Victoria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.